AGENDA AT A GLANCE
Day 1
11 March 2026
Leadership Panel: Is Asia Ready to Lead the AI Biopharma Revolution?
Regional Strengths, Challenges & Leadership Pathways
8:50
Chairman Opening Remarks
9:00
Panel Discussion: Is Asia Ready to Lead the AI Biopharma Revolution?
- Assessing Asia’s readiness for AI integration across the biopharma value chain.
- Unlocking innovation through AI-driven discovery and development.
- Transforming manufacturing with data intelligence and digital twins.
- Strengthening regulatory harmonisation and ethical governance.
- Building collaboration networks and future-ready talent across the region.
Panelists:
9:50
Reserved for IDBS
Intelligent Discovery & Molecular Design
AI-enabled Discovery, Predictive Modelling & Next-Gen Biologics
10:15
Accelerating Drug Discovery through Multimodal Data Integration
- Integrating omics, imaging, and clinical data to create unified AI models for drug discovery.
- Strengthening target identification, drug efficacy predictions, and patient stratification.
- Overcoming data silos to enable a more efficient and predictive discovery pipeline.
10:40
Morning Break – Exhibition Viewing & 1-1 Networking
Digital Biomanufacturing & Process Innovation
Smart Bioprocessing, Automation & Digital Twins
11:25
Reserved for Solution Provider
12:15
Lunch – Exhibition Viewing & 1-1 Networking
Data-Driven Quality, Compliance & Regulatory Excellence
Digital Validation, Intelligent QA & Global Alignment
2:25
Reserved for Solution Providers
2:50
Leveraging AI and Digital Tools for Regulatory Success Across the Biopharma Value Chain
- Enhancing regulatory submission accuracy with AI-driven data analysis and automated documentation.
- Streamlining compliance monitoring through digital tools that integrate R&D, manufacturing, and distribution.
- Improving audit readiness and data integrity by automating risk management processes with AI.
3:15
Afternoon Break – Exhibition Viewing & 1-1 Networking
Ethics, Governance & Trust in the Digital Era
Transparency, Cybersecurity & Responsible Innovation
4:00
Building Responsible AI Frameworks for Biopharma
- Defining ethical guidelines and governance for AI use.
- Building audit trails and explainable decision-making processes.
- Aligning AI development with regulatory and ethical standards.
4:25
Reserved for Solution Providers
4:50
Securing AI-Driven Biopharma Systems and Protecting Intellectual Property
- Implementing robust cybersecurity measures to protect AI models and data integrity.
- Securing sensitive training data and ensuring AI system transparency.
- Protecting intellectual property and ensuring compliance with global security standards.
5:15
Chairman Closing Remarks
5:20
End of Conference - Day 1
5:20
Cocktails & Networking
6:00
ABEA Awards 2026
For Speaking Opportunities, Kindly Contact:
